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In Vitro Oral Biofilm Formation
on Triclosan-Coated Sutures in the
Absence and Presence of Additional
Antiplaque Treatment
Sebastiaan Venema, DMD,* Frank Abbas, PhD,†
Betsy van de Belt-Gritter, BASc,‡ Henny C. van der Mei, PhD,§
Henk J. Busscher, PhD, MSc, and
Chris G. van Hoogmoed, PhD¶
Purpose: This study evaluated the in vitro plaque inhibitory effect of triclosan-coated polyglactin 910
sutures in the absence and presence of an additional antiplaque agent commonly used after oral surgery.
Materials and Methods: Triclosan-coated sutures were incubated for 4 hours in freshly collected
human saliva and, when appropriate, subsequently treated with an antiplaque rinse containing
chlorhexidine-cetyl pyridinium as active components. Sutures without a triclosan-coating served as a
control.
Results: Triclosan-coated sutures harbored similar amounts of plaque as did uncoated sutures. Expo-
sure to the antiplaque rinse caused significant decreases in viable organisms for uncoated and triclosan-
coated sutures. However, after application of the antiplaque rinse, more micro-organisms were found on
triclosan-coated than on uncoated sutures.
Conclusion: Sutures coated with triclosan do not provide a sufficient antimicrobial effect to prevent in
vitro colonization by oral bacteria, whereas use in combination with a chlorhexidine-cetyl pyridinium–
containing antiplaque rinse appears to be counterproductive.
© 2010 American Association of Oral and Maxillofacial Surgeons














0utures are used frequently in oral surgery, for in-
tance, after the surgical removal of third molars,
mplant surgery, and a variety of periodontal proce-
ures. Sutures used in the oral cavity, however, be-
ome rapidly covered with dental plaque or biofilm,
roviding a reservoir of pathogens that may cause
nflammation of neighboring tissue. The incidence of
nfections after third molar surgery is 1% to 5% and
he reported overall prevalence of periodontal post-
urgical infections varies from less than 1% to 5.4%.1-4
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1In general surgery, skin-derived Staphylococcus au-
eus and Enterococcus sp are held responsible for most
ostsurgical wound infections.5,6 However, the oral mi-
roflora contains many other specific opportunistic
athogens, such as streptococci, Bacteroides, Fusobac-
eria, Prevotella, and Porphyromonas, whichmay ham-
er oral wound healing7,8 or act as a focus for postsur-
ical, odontogenic infections.9,10
Postsurgical infections are accompanied by high
osts and patients’ inconvenience, because they often
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2 EFFICACY OF TRICLOSAN-COATED SUTURES
ARTICLE IN PRESSequire additional surgery, extended hospitalization,
nd use of antibiotics or other oral antimicrobials. In
eneral, however, once bacteria are in a biofilm mode
f growth, their susceptibility to antibiotics and other
ntimicrobials is low. Postsurgical care regimens typ-
cally involve chlorhexidine rinsing to avoid plaque
ormation,11,12 although the efficacy of chlorhexidine
trongly decreases when a biofilm matures.13 Tri-
losan is another antimicrobial agent widely used in
ersonal care and hygiene products such as deodorants
nd soaps and in oral health products to decrease plaque
ormation and treat inflammatory lesions.14,15 Recently,
riclosan-coated polyglactin 910 sutures have been intro-
uced and demonstrated to be effective in preventing
uture-colonization by wild-type and methicillin-resis-
ant S aureus and Staphylococcus epidermidis.16
The aim of the present work was to determine the
fficacy of triclosan-coated sutures on oral biofilm
ormation in vitro in the absence and presence of the




Sterile polyglactin 910 sutures (size 3-0) were used
ith and without a triclosan (2,2,4-trichloro-2-hy-
roxy-diphenyl ether) coating, ie, Vicryl Plus Antibac-
erial and Vicryl (Johnson & Johnson Medical BV,
mersfoort, The Netherlands). Both sutures are ab-
orbable, braided, and violet colored and were ob-
ained in sterile packages. Vicryl Plus Antibacterial
ontains triclosan up to 150 g/m. Control experi-
ents were performed to check the antibacterial ef-
cacy of the triclosan-coated sutures used by measur-
ng the zone of inhibition around a streptococcal and
taphylococcal strain. To this end, Streptococcus san-
uis PK1889 and S aureus O were precultured from
lood agar in 10 mL of Todd Hewitt Broth (Oxoid,
asingstoke, UK) or Tryptone Soya Broth (Oxoid),
espectively, for 24 hours at 37°C in ambient air. From
ach preculture, blood agar plates were prepared.
fter placing 1 length of a triclosan-coated suture on
he inoculated blood agar plates, plates were incu-
ated at 37°C for 48 hours in ambient air. Subse-
uently, the plates were scanned for a zone of inhi-
ition around the triclosan-coated suture. In addition,
lood agar plates were inoculated with human whole
aliva to observe possible zones of inhibition around
he sutures for the mixed, total salivary microflora (for
aliva collection, see below).
ANTIPLAQUE RINSE
Perio-aid (Dentaid BeNeLux BV, Houten, The Neth-
rlands), containing 0.12% chlorhexidine, 0.05% cetyl ayridinium chloride, and no alcohol, was used as an
ntiplaque rinse.
COLLECTION AND MICROBIAL COMPOSITION
OF SALIVA
Fresh human whole saliva was used as an inoculum
or biofilm formation on the sutures and was obtained
rom a pool of 28 healthy female and male donors.
aliva was collected into ice-chilled cups, after stim-
lation of the salivary flow by chewing Parafilm
Pechiney Plastic Packaging, Chicago, IL), in line with
he rules set out by the medical ethical committee of
he University Medical Center Groningen and the te-
ets of the Declaration of Helsinki and with the in-
ormed consent of the donors. After collection and
ooling, phenylmethylsulfonyl fluoride (0.2 mol/L;
erck, Darmstadt, Germany) was added to a final
oncentration of 1 mmol/L as a protease inhibitor.
ubsequently, the microbial composition of the
ooled saliva was determined by dilution plating.
o determine the total number of cultivable micro-
rganisms in saliva, dilution plating was done on
heep blood agar (50 mL/L) supplemented with he-
in (5 mL/L) and menadione (1 mL/L) and incubated
or 14 days under anaerobic conditions at 37°C. The
ollowing selective plates were used: TYS20B agar17
or Streptococcus mutans, which was incubated for 5
ays anaerobically at 37°C followed by 2 days aerobi-
ally at 20°C; MSB agar18 for Streptococcus mitis and
treptococcus salivarius, which was incubated for 2
ays aerobically; and MRS agar (Merck) for lactoba-
illi, which was incubated for 2 days with 5% CO2.
fter incubation, colony-forming units (CFUs) were
ounted. Nonagreeable species to the selective agar
lates were excluded based on morphology by micro-
copic analysis.
BIOFILM FORMATION ON SUTURES
Sterile test tubes were filled with 60 mL of fresh
uman saliva and sealed with cotton wool. Two
engths (5 cm each) of triclosan-coated and uncoated
utures were put into the saliva through the cotton
ool until the sutures were totally submerged. Incu-
ation was done for 4 hours while shaking (New
runswick Scientific Classic 24, Edison, NJ) at 37°C
nd 60 rpm to simulate saliva flow around the sutures.
fter incubation, all sutures were rinsed in sterile
educed transport fluid (RTF).19 One of the 2 lengths
as put in a sterile cup with 1.5 mL of sterile RTF.
he other length was immersed in 15 mL of the
ntiplaque rinse and hand-shaken for 30 seconds. Sub-
equently, this length was rinsed in sterile RTF and
ut in a cup with 1.5 mL of sterile RTF. Biofilm






































VENEMA ET AL 3
ARTICLE IN PRESSBIOFILM ANALYSIS
Selective plate counting was applied to enumerate
he number of viable organisms on the sutures, and
ntact biofilms on the sutures were examined using
onfocal laser scanning microscopy (CLSM). For se-
ective plate counting, adhering bacteria were de-
ached from the sutures by sonication in RTF for 30
econds (3 times 10 seconds with a 20-second inter-
al) at 30 W, 90% duty cycle, and a microtip output
imit of 2.5 (Vibra Cell model 375; Sonics and Materi-
ls Inc, Danbury, CT) while cooling in an ice-water
ath. Subsequently, the resulting bacterial suspen-
ions were dilution plated, as described above. Aver-
ge CFUs were calculated for all types of agar plates
nd converted to log values per centimeter of suture
IGURE 1. Presence of a zone of inhibition around a triclosan-coated
uture against triclosan-sensitive Staphylococcus aureus O.






treptococcus mitis/Streptococcus salivarius 6.6
actobacilli 6.8
otal number of micro-organisms 7.9
bbreviation: CFU, colony-forming unit.
enema et al. Efficacy of Triclosan-Coated Sutures. J Oral Maxil-
ofac Surg 2010.i
enema et al. Efficacy of Triclosan-Coated Sutures. J Oral Maxillofac
urg 2010.ength. CLSM was applied to check whether sonica-
ion had indeed removed all bacteria from the suture.
All quantitative analyses were carried out at least in
riplicate. The statistical significance of differences
etween 2 means was examined by paired Student’s t
est, and P less than .05 was considered a significant
tatistical difference.
For CLSM analysis of the biofilms, sutures with
IGURE 2. Absence of zones of inhibition around triclosan-coated
utures against Streptococcus sanguis PK1889 (A) and total sali-
ary microflora (B). B, Note that oral microflora has excreted a
limy layer over the suture. Arrowheads indicate the tips of the
uture.
enema et al. Efficacy of Triclosan-Coated Sutures. J Oral Maxil-









































































4 EFFICACY OF TRICLOSAN-COATED SUTURES
ARTICLE IN PRESSaclight Bacterial Viability Kit (Molecular Probes, Lei-
en, The Netherlands). This stain contains SYTO9 dye
3.34 mmol/L) and propidium iodide (20 mmol/L). The
LSM used was a Leica TCS SP2 (Leica Microsystems
eidelberg GmbH, Heidelberg, Germany), equipped
ith a 20 oil immersion objective. Emission wave-
engths were 500 to 600 nm at an excitation wave-
ength of 488 nm for detection of the green fluores-
ent SYTO9 and 560 to 700 nm at an excitation
avelength of 543 nm for detection of the red fluo-
escent propidium iodide. Viable bacteria exhibit
reen fluorescence, whereas dead bacteria exhibit
ed fluorescence. Representative images were taken
f each suture by scanning series of about 40 images
with steps of 3 m) and stacked into overlay projec-
ions.
esults
The concentrations in saliva of the different bacterial
roups are presented in Table 1. During the experimen-
al period, bacterial concentrations of the pooled saliva
ere regularly checked and found to coincide within
.1 log10 CFU/mL. The control experiment for S aureus
 was positive (Fig 1) and a zone of inhibition with a
iameter of 6mmwas observed. In addition, no zones of
nhibition were observed for S sanguis PK1889 (Fig 2A)
nd the total salivary microflora (Fig 2B).
There was no significant difference in the number
f CFUs found on sutures with or without a triclosan
oating (Table 2), in line with the absence of zones of
nhibition around triclosan-coated sutures on plates
noculated with streptococci or total salivary micro-
ora (Fig 2). On both types of sutures, the number of
FUs for all bacterial groups decreased significantly
P  .05, paired Student’s t test) after additional anti-
Table 2. NUMBER OF VIABLE ORGANISMS (LOG10 UNI






treptococcus mitis/Streptococcus salivarius 4.4
actobacilli 4.0
otal number of micro-organisms 5.9
bbreviations:APR, absence of additional antiplaque rinse
etected.
Values for specific bacterial groups are presented as me
icro-organisms was determined in 5 separate experiment
*P  .05 versus APR in the absence and presence of a
†P  .05 versus with triclosan coating and APR.
‡P  .05 versus with triclosan coating and APR.
enema et al. Efficacy of Triclosan-Coated Sutures. J Oral Maxilllaque treatment. However, use of a chlorhexidine-cetyl tyridinium–containing antiplaque rinse on biofilms
ormed on triclosan-coated sutures yielded more viable
rganisms than on biofilms formed on uncoated sutures
P  .05, paired Student’s t test).
Numbers of green fluorescent, live bacteria on su-
ures without and with triclosan-coating were similar
compare Figs 3A,B, respectively), in correspondence
ith the data listed in Table 2. Use of the chlorhexidine-
etyl pyridinium–containing antiplaque rinse yielded an
ncrease in red fluorescence for both types of sutures
Figs 3C,D), indicating a decrease in the number of
iable bacteria.
iscussion
Biofilm formation on oral sutures can act as a focus of
nfection and form a potential risk for wound healing
fter oral surgery. Good sutures require specific physical
haracteristics and properties to limit or prevent bacte-
ial colonization of parts exposed to saliva. Currently,
ifferent types of synthetic sutures are used in oral
urgery, monofilament versus multifilament and
esorbable versus nonresorbable. In general, mono-
lament and resorbable sutures show less biofilm
ormation than multifilament and nonresorbable su-
ures.20-22 A recent effort aimed at further decreas-
ng suture-mediated infections by triclosan coating
f polyglactin 910 sutures.
Triclosan, a phenyl ether, is predominantly bacterio-
tatic. At low concentrations the growth of many gram-
ositive and gram-negative nonsporulating bacteria is
nhibited.15 Its spectrum includes minimum inhibitory
oncentration (MIC) values in the order of lower than
.001 to 7.8 g/mL for a range of oral bacterial strains
ultured in broth. However, these MIC values increase
hen protein is added to the growth media.23 Above
CENTIMETER SUTURE) IN BIOFILMS ON SUTURES
AND PRESENCE OF AN ADDITIONAL ANTIPLAQUE
Triclosan Coating With Triclosan Coating
APR APR APR
ND*†‡ 4.5  0.4 1.6 0.6*
ND*†‡ 4.2  0.5 1.3 1.3*
ND*†‡ 4.5  0.6 0.7 0.8*
1.6 1.4*†‡ 6.1  0.5 3.1 0.8*
, presence of additional antiplaque rinse; ND, no organisms

















































VENEMA ET AL 5
ARTICLE IN PRESSriclosan is formulated into toothpastes and mouth-
inses in concentrations up to 0.3% (3 mg/g) and 0.03%
0.3 mg/mL), respectively. This is much higher than the
ited MIC values. However, in vivo, the antiplaque effi-
acy of triclosan alone is limited24,25 due to lack of
ubstantivity. Oral retention of triclosan has been in-
reased through the inclusion of polyvinyl methyl ether
aleic acid. Furthermore, its antimicrobial effect has
een increased in oral health care products through the
ddition of zinc citrate.26-29
The antimicrobial effect of triclosan-coated sutures
as been shown only for nonoral, single species, such
s S aureus, S epidermidis, and Escherichia coli,16,30
ut its use in oral health care products suggests benefits
f the use of triclosan-coated sutures in oral surgery.
herefore, the total lack of efficacy of a triclosan
IGURE 3. Examples of CLSM images from sutures without (A, C) a
o chlorhexidine-cetyl pyridinium–containing antiplaque rinse. Flu
onviable bacteria. Note that the color of the suture filaments itsel
enema et al. Efficacy of Triclosan-Coated Sutures. J Oral Maxilloating on oral biofilm formation (Figs 3A,B; Table 2) fias surprising. Although the efficacy of the triclosan-
oated sutures against a triclosan-sensitive S aureus
 strain was confirmed (Fig 1), the triclosan-coated
utures yielded no measurable zones of inhibition
gainst the oral bacteria (Figs 2A,B). This is in line
ith suggestions that antimicrobial effects of tri-
losan-containing toothpastes and mouth rinses are
ot solely due to triclosan, but rather to its combina-
ion with polyvinyl methyl ether maleic acid or zinc
itrate triclosan.26-29
Chlorhexidine, a cationic agent with hydrophilic and
ydrophobic properties, is still the leading antimicrobial
o combat supragingival and mucosal plaques. It is often
rescribed after oral surgery, when mechanical
laque control is limited or impossible. Combination
f chlorhexidine with other antimicrobials might at
h (B, D) a triclosan coating before (A, B) and after (C, D) exposure
nt green represents viable bacteria (arrow in A); red represents
from olive green (A, C, D) to brown (B).
rg 2010.nd wit
oresce





















































6 EFFICACY OF TRICLOSAN-COATED SUTURES
ARTICLE IN PRESSroved otherwise. Combination of chlorhexidine
ith anionic sodium lauryl sulfate, a detergent used in
any dentifrices, has been demonstrated to cause
nactivation of chlorhexidine.31-33 In this study, use of
chlorhexidine-cetyl pyridinium antiplaque rinse on
ral biofilms formed on triclosan-coated sutures also
ppeared to be disadvantageous. This may have major
linical consequences, because more bacteria sur-
ived the combination than found on uncoated con-
rol sutures (Figs 3C,D and Table 2). In contrast to
odium lauryl sulfate, triclosan is nonionic, and elec-
rostatic interactions between chlorhexidine and tri-
losan probably do not form the basis for this inacti-
ation. Possibly, hydrophobic interactions between the
ationic chlorhexidine and cetyl pyridinium with tri-
losanmolecules, possessing hydrophilic and hydropho-
ic properties, form the basis for the inactivation ob-
erved.
Summarizing, the present results indicate that the
se of triclosan-coated sutures yields no benefits in
he control of oral biofilms. Moreover, its use in
ombination with cationic antiplaque agents, such
s chlorhexidine and cetyl pyridinium, as is com-
on practice in oral surgery, seems to be counter-
ndicated when triclosan-coated sutures are applied.
cknowledgments
This study was supported by the University Medical Center
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